Bouzid, Kenza http://orcid.org/0000-0001-5864-2792
Sharma, Harshita http://orcid.org/0000-0003-4683-2606
Killcoyne, Sarah http://orcid.org/0000-0003-3686-6167
Castro, Daniel C. http://orcid.org/0000-0002-6829-7045
Schwaighofer, Anton http://orcid.org/0000-0003-1557-0527
Ilse, Max
Salvatelli, Valentina http://orcid.org/0000-0002-3232-4101
Oktay, Ozan http://orcid.org/0000-0003-2976-0874
Murthy, Sumanth
Bordeaux, Lucas
Moore, Luiza
O’Donovan, Maria
Thieme, Anja http://orcid.org/0000-0002-9639-5531
Nori, Aditya
Gehrung, Marcel
Alvarez-Valle, Javier http://orcid.org/0000-0003-0906-4177
Article History
Received: 1 September 2023
Accepted: 15 February 2024
First Online: 11 March 2024
Competing interests
: M.O.D. is named on patents (”Cell Sampling Device” US10327742B2 ”Biomarker for Barrett’s esophagus” US10551392B2) related to Cytosponge that have been licensed to COVIDien (now Medtronic) and is a co-founder of Cyted Ltd. S.K., S.M., L.B., and M.O.D. are employees of Cyted Ltd that provides the diagnostic testing for the capsule sponge product. M.G. is a co-founder and CEO of Cyted Ltd. The remaining authors declare no competing interests.